Investments
85Portfolio Exits
16About Tao Capital Partners
Tao Invest, the direct investment entity affiliated with Tao Capital Partners, invests in technology, alternative energy, healthcare, and real estate businesses that have a sustainable positive impact. Tao is an active investor with the ability to support companies through various stages of their life-cycle.
Tao Capital Partners Headquarter Location
San Francisco, California,
United States
Expert Collections containing Tao Capital Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Tao Capital Partners in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Research containing Tao Capital Partners
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Tao Capital Partners in 1 CB Insights research brief, most recently on Jul 15, 2019.
Latest Tao Capital Partners News
May 5, 2022
Other new investors Alpha Wave Ventures, NexPoint also participated in the round along with existing investors Morningside Ventures, Seligman Investments, and Tao Capital Partners. Apnimed will use the The post Apnimed raises funding to advance new treatments development for OSA appeared first on Pharmaceutical Business review.
Tao Capital Partners Investments
85 Investments
Tao Capital Partners has made 85 investments. Their latest investment was in Vizgen as part of their Series C on May 5, 2022.
Tao Capital Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/5/2022 | Series C | Vizgen | $85.2M | No | ARCH Venture Partners, Blue Water Life Science Advisors, David Walt, Northpond Ventures, Novalis LifeSciences, Sofina, and Undisclosed Investors | 2 |
5/4/2022 | Series C | Apnimed | $62.5M | No | 5Y Capital, Alpha Wave Global, NexPoint, Sectoral Asset Management, Seligman Investments, and Undisclosed Investors | 3 |
4/21/2022 | Series C | Crusoe | $350M | Yes | Atreides Management, Bain Capital Ventures, Castle Island Ventures, CMT Digital, DRW Venture Capital, Engine No. 1, EXOR Seeds, Felicis, Footprint Coalition Ventures, Founders Fund, G2VP, Inclusive Capital Partners, Lowercarbon Capital, MCJ Collective, Mitsui & Co., Polychain Capital, Undisclosed Investors, Upper90, Valor Equity Partners, Winklevoss Capital, and Zigg Capital | 4 |
3/22/2022 | Series D | |||||
2/15/2022 | Series D |
Date | 5/5/2022 | 5/4/2022 | 4/21/2022 | 3/22/2022 | 2/15/2022 |
|---|---|---|---|---|---|
Round | Series C | Series C | Series C | Series D | Series D |
Company | Vizgen | Apnimed | Crusoe | ||
Amount | $85.2M | $62.5M | $350M | ||
New? | No | No | Yes | ||
Co-Investors | ARCH Venture Partners, Blue Water Life Science Advisors, David Walt, Northpond Ventures, Novalis LifeSciences, Sofina, and Undisclosed Investors | 5Y Capital, Alpha Wave Global, NexPoint, Sectoral Asset Management, Seligman Investments, and Undisclosed Investors | Atreides Management, Bain Capital Ventures, Castle Island Ventures, CMT Digital, DRW Venture Capital, Engine No. 1, EXOR Seeds, Felicis, Footprint Coalition Ventures, Founders Fund, G2VP, Inclusive Capital Partners, Lowercarbon Capital, MCJ Collective, Mitsui & Co., Polychain Capital, Undisclosed Investors, Upper90, Valor Equity Partners, Winklevoss Capital, and Zigg Capital | ||
Sources | 2 | 3 | 4 |
Tao Capital Partners Portfolio Exits
16 Portfolio Exits
Tao Capital Partners has 16 portfolio exits. Their latest portfolio exit was Greenlight Biosciences on February 03, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/3/2022 | Reverse Merger | 3 | |||
1/19/2022 | Reverse Merger | 13 | |||
11/8/2021 | Acq - Fin - II | 1 | |||
Date | 2/3/2022 | 1/19/2022 | 11/8/2021 | ||
|---|---|---|---|---|---|
Exit | Reverse Merger | Reverse Merger | Acq - Fin - II | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 3 | 13 | 1 |
Tao Capital Partners Team
2 Team Members
Tao Capital Partners has 2 team members, including current Managing Director, Thomas Clancy.
Name | Work History | Title | Status |
|---|---|---|---|
Thomas Clancy | WineDirect, Enterprise Partners Venture Capital, Expersoft, and Citigroup | Managing Director | Current |
Joby Pritzker | Managing Director | Current |
Name | Thomas Clancy | Joby Pritzker |
|---|---|---|
Work History | WineDirect, Enterprise Partners Venture Capital, Expersoft, and Citigroup | |
Title | Managing Director | Managing Director |
Status | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.